Ушбу иш иқтибос қилган ишлар

149 та иш

Иш: Immunological functions of Th17 Cells in colon cancer: From pathogenic mechanisms to emerging treatments

1. Regulatory T-cell Response to Enterotoxigenic <i>Bacteroides fragilis</i> Colonization Triggers IL17-Dependent Colon Carcinogenesis

   Abby L. Geis, Hongni Fan, Xinqun Wu +6

   Мақола20152 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.339879

2. Local and systemic Th17 immune response associated with advanced stage colon cancer

   Stephen P. Sharp, Dorina Avram, Steven C. Stain +1

   Мақола20162 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.355486

3. Global cancer statistics of young adults and its changes in the past decade: Incidence and mortality from GLOBOCAN 2022

   Jian Li, Xiaohong Kuang

   Мақола20242 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.447292

4. <i>CCAT2</i>, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

   Hui Ling, Riccardo Spizzo, Yaser Atlasi +50

   Мақола20132 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.472408

5. TRPC1 and TRPC5 in Colorectal Cancer: Mechanisms, Prognostic Markers, and Therapeutic Targets

   Manal A. Abbas, Aya Y. Al‐Kabariti, Randa El‐Rayyes +2

   Шарҳ мақола20252 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.472511

6. Robust tumor immunity to melanoma mediated by interleukin-9–producing T cells

   Rahul Purwar, Christoph Schlapbach, Sheng Xiao +9

   Мақола20122 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.801791

7. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression

   Farnaz Hajizadeh, Sadaf Moghadaszadeh Ardebili, Mahdi Baghi Moornani +12

   Мақола20202 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.837941

8. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer

   Chao Liu, Ruiqi Liu, Bojun Wang +13

   Мақола20212 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.837944

9. The role of <scp>SF3B1</scp> and <scp>NOTCH1</scp> in the pathogenesis of leukemia

   Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh +5

   Шарҳ мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.837954

10. Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses

    Sara Adibfar, Ali Masjedi, Atefeh Nazer +9

    Мақола20222 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837957

11. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837854

12. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837855

13. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837856

14. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837857

15. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837858

16. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837859

17. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837860

18. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837861

19. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837862

20. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837863

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837864

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837865

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837866

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837867

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.837868